From 03.10.2020 to 05.10.2020

Starts at 9:00 until 14:30

7th Immunotherapy of Cancer Conference

Venue: Munich
Speaker: Several.
Organizer: WMA GmbH
Language: English
Registration necessary: yes

In view of the spread of coronavirus (COVID-19), the conference is postponed from April 2-4, 2020 to October 3-5, 2020.

The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from April 2 – 4, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.

ITOC7 is organised by the WMA GmbH  in scientific cooperation with the Tumor Centre in Munich (TZM),the Society for Immunotherapy of Cancer (SITC) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.

The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

More information can be accessed on this webpage.

Registration can be done on this webpage.

Scientific Program

Wir setzen Cookies ein, um unsere Website nutzerfreundlicher zu gestalten. Weitere Informationen erhalten Sie in der Datenschutzerklärung. Zur Datenschutzerklärung.